Appropriateness of percutaneous revascularization of coronary chronic total occlusions: an overview
Alfredo R Galassi1, Emmanouil S Brilakis2, Marouane Boukhris3
1Department of Clinical and Experimental Medicine, Catheterization Laboratory and Cardiovascular Interventional Unit, Cannizzaro Hospital, University of Catania, Via Antonello da Messina 75, Acicastello, 95021 Catania, Italy argalassi@gmail.com.
Insights
Successful revascularization of coronary chronic total occlusions (CTOs) improves cardiovascular outcomes and quality of life. Despite growing interest and guideline recommendations, the full prognostic benefit of CTO percutaneous coronary intervention (PCI) requires further study.
Area of Science:
- Interventional Cardiology
- Cardiovascular Medicine
- Vascular Biology
Background:
- Coronary chronic total occlusions (CTOs) are frequently identified during coronary angiography.
- Observational studies suggest successful CTO revascularization improves cardiovascular outcomes and quality of life (QOL).
- The definitive prognostic benefit of CTO revascularization remains debated due to a lack of randomized trials.
Purpose of the Study:
- To review the impact of CTO revascularization on clinical outcomes and QOL.
- To discuss appropriate patient selection for CTO percutaneous coronary intervention (PCI).
- To critically assess current guidelines and recommendations for CTO PCI.
Main Methods:
- Review of observational studies and clinical data on CTO revascularization.
- Analysis of advancements in dedicated equipment and techniques for CTO PCI.
- Evaluation of European and American guideline recommendations for CTO PCI.
Main Results:
- Significant advancements in CTO PCI techniques and equipment have led to high success and low complication rates.
- Successful CTO revascularization is associated with improved cardiovascular outcomes and QOL.
- CTO PCI holds a Class IIa recommendation (Level B evidence) in major guidelines.
Conclusions:
- CTO PCI is increasingly recognized for its potential to improve patient outcomes and QOL.
- Appropriate patient selection is crucial for optimizing the benefits of CTO revascularization.
- Further research, including randomized trials, may be needed to solidify the prognostic value of CTO PCI.
Abstract:
Coronary chronic total occlusions (CTOs) are commonly encountered in patients undergoing coronary angiography. Several observational studies have demonstrated that successful CTO revascularization is associated with better cardiovascular outcomes and enhanced quality of life (QOL). However, in the absence of randomized trials, its prognostic benefit for patients remains debated. Over the past decade, the interest of the interventional community in CTO percutaneous coronary intervention (PCI) has exponentially grown due to important developments in dedicated equipment and techniques, resulting in high success and low complication rates. Both European and American guidelines have assigned a class IIa (level of evidence B) recommendation for CTO PCI. In the current review, we focus on the impact of CTO revascularization on clinical outcomes and QOL and on appropriate patient selection, and we provide a critical assessment of the current guidelines and recommendations on CTO PCI.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
06:30Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock
Published on: May 19, 2022
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Continuous Renal Replacement Therapy
Acute Coronary Syndrome IV: Interprofessional Care
